Solidification/stabilization of Cr(VI) with cement: Leachability and XRD analyses

The leachability of Cr(VI) from solidified Cr(VI)–Portland cement mixtures cured for 28 days were investigated. Cr(VI) was solidified with Type I Portland cement at concentrations of 0.5%, 2%, and 5% (based on K 2CrO 4) by weight of the cement. The addition of Cr(VI) increased the initial and final...

Full description

Saved in:
Bibliographic Details
Published inCement and concrete research Vol. 30; no. 3; pp. 385 - 389
Main Authors Wang, S., Vipulanandan, C.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Ltd 2000
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The leachability of Cr(VI) from solidified Cr(VI)–Portland cement mixtures cured for 28 days were investigated. Cr(VI) was solidified with Type I Portland cement at concentrations of 0.5%, 2%, and 5% (based on K 2CrO 4) by weight of the cement. The addition of Cr(VI) increased the initial and final setting times of cement. X-ray diffraction (XRD) study indicates that Cr(VI) inhibits cement hydration process by reacting with Ca 2+ during the hydration of cement, which was also supported by increased setting times. Increasing the Cr(VI) content in the cement reduced the compressive strength of the solidified cement. The leachability of Cr(VI) during the toxicity characteristics leaching procedures (TCLP) test was dependent on the initial Cr(VI) concentration and the leaching time. The treatment efficiency of cement was independent of the initial Cr(VI) concentration. The reaction products and crystalline phases were identified using the XRD. One of the reaction products identified was CaCrO 4. An empirical relationship was developed to predict the leaching of Cr(VI). Based on this relationship, the treatable amount should be limited to K 2CrO 4/cement ratio of 0.2% to meet the TCLP limit of 5 mg/l.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0008-8846
1873-3948
DOI:10.1016/S0008-8846(99)00265-3